This company specializes in ophthalmic pharmaceuticals, focusing on products for eye care. Their product portfolio includes a range of therapeutic solutions addressing various eye conditions such as glaucoma, inflammation, infections, and dryness. Key dosage forms include eye drops, with active ingredients like brinzolamide, timolol, chloramphenicol, ciprofloxacin, dorzolamide, latanoprost, cyclosporine, and many others. The company prioritizes innovation and has developed a line of preservative-free products for patients with chronic ophthalmological diseases. They emphasize their commitment to quality by adhering to GMP certifications and holding product patents. The company serves markets in the EU and North America.